Anuh Pharma Limited has announced the successful completion of an inspection conducted by the United States Food and Drug Administration (USFDA) at its manufacturing facilities in Tarapur (Boisar), Palghar, Maharashtra. The inspection, which covered the facilities located at E-17/3, E-17/4, and E-18, MIDC, Tarapur, concluded without any Form 483 observations being issued. This outcome highlights the company's consistent adherence to stringent global regulatory and quality compliance standards. The disclosure, available on the company's website, reaffirms Anuh Pharma's commitment to maintaining high-quality manufacturing practices.
